Friday, June 9, 2017

FDA Requests Reformulated Oxymorphone Product Removed for ...

Pharmacy Times-16 hours ago
Officials with the FDA have requested that Endo Pharmaceuticals remove its opioid pain medication, oxymorphone hydrochloride (reformulated Opana ER), from ...

No comments: